About this program
Why H. pylori still matters in the Middle East
H. pylori infection is a well-established disease, yet antimicrobial resistance and ongoing unmet needs continue to create challenges in its management across the region. Treatments that worked a decade ago now fail more often, and testing practices vary widely between countries.
This program has been developed to support healthcare professionals in optimizing H. pylori management, from choosing the right patients and tests to selecting effective therapy. The First Regional Middle East Consensus is the key scientific reference throughout.